Brean Murray Carret & Co.
http://www.breanmurraycarret.com/
Brean Murray & Co., Inc. was founded in 1973 as a research-driven investment and merchant bank, focusing on growth companies to provide clients with superior investment opportunities.
Brean Murray's services include equity research, investment banking, institutional sales and trading, syndicate, and asset management. The Company's clients include institutional investors, high net worth individuals and corporations that use its capital markets services to take advantage of compelling market opportunities.
Brean Murray, Carret & Co. has also established a presence in Beijing, bringing over three decades of investment banking and brokerage experience to mainland China.
Brean Murray Carret & Co. maintains a 'Buy' on Regeneron Pharma (REGN); Adjusting Eylea Sales Upward
-
Notable Analyst Rating Changes 09/09: (DB) (SUN) (TWX) Upgraded; (RIMM) (REGN) (SNY) Downgraded
-
Morning Movers 04/29: (SPWRA) (NTGR) (ACOM) (ASGN) Higher; (KVHI) (SUNH) (KND) (RIMM) Lower
-
Brean Murray Carret & Co. Raises Price Target on Regeneron Pharma (REGN) Following Yesterdays Announcment on Phase 3 GALILEO Trial
-
Brean Murray Carret & Co. Raises Price Target on Regeneron Pharma (REGN) Following Yesterdays Announcment on Zaltrap
-
Brean Murray Carret & Co. Raises Price Target on Regeneron Pharma (REGN) Following Priority Review Rating for VEGF Trap Eye
-
Canaccord Genuity Morning Coffee on Regeneron Pharma (REGN): Stick a Needle in My Eye
-
Brean Murray Initiates Coverage on Regeneron Pharmaceuticals (REGN) with a Buy; Results of Phase 3 Trials to Add Substantial Value